SCHEMBL4809975

SCHEMBL4809975

Oc1cccc2c1Cc1ccccc1CO2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.47
DRD3 P35462 2/20 0.47
DRD1 P21728 1/20 0.47
DRD5 P21918 1/20 0.47
BCL2L1 Q07817 1/20 0.41
BAD Q92934 1/20 0.41
HSD17B3 P37058 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
HPN P05981 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1980248 0.79 MAOA (0.59) DRD2DRD3DRD1DRD5BCL2L1
Bromide SCHEMBL6129306 0.78 MAOA (0.57) DRD2DRD3DRD1DRD5BCL2L1
SCHEMBL8468364 0.78 MAOA (0.38) HSD17B3MAOAMAOBALDH1A1KMT2A
SCHEMBL7729132 0.77 NPC1 (0.36) DRD2DRD3DRD1DRD5HSD17B3
SCHEMBL7918691 0.76 DRD2 (0.61) DRD2DRD3DRD1DRD5BCL2L1
SCHEMBL31634362 0.76 DRD2 (0.61) DRD2DRD3DRD1DRD5BCL2L1
SCHEMBL7506305 0.74 ALDH1A1 (0.36) DRD2DRD3DRD1DRD5HSD17B3
SCHEMBL489968 0.73 MAOA (0.61) DRD2DRD3DRD1DRD5HSD17B3
SCHEMBL10585516 0.73 AKR1B1 (0.42) HSD17B3ALDH1A1PTGS1HSD17B10TDP1
SCHEMBL6907788 0.73 DRD2 (0.52) DRD2DRD3DRD1DRD5BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008070795-A2 COMBINATION THERAPY USING LOW-DOSE DOXEPIN FOR THE IMPROVEMENT OF SLEEP SOMAXON PHARMACEUTICALS, INC. (US) 2008-06-12 WO disclosed